MENU
+Compare
ARGX
Stock ticker: NASDAQ
AS OF
Jun 9, 02:57 PM (EDT)
Price
$584.47
Change
-$1.46 (-0.25%)
Capitalization
36.1B

ARGX argenx SE Forecast, Technical & Fundamental Analysis

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARGX with price predictions
Jun 06, 2025

Momentum Indicator for ARGX turns positive, indicating new upward trend

ARGX saw its Momentum Indicator move above the 0 level on June 06, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ARGX just turned positive on May 23, 2025. Looking at past instances where ARGX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARGX advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

ARGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 247 cases where ARGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ARGX moved out of overbought territory on May 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where ARGX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

ARGX moved below its 50-day moving average on May 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ARGX crossed bearishly below the 50-day moving average on May 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for ARGX moved below the 200-day moving average on May 30, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.506) is normal, around the industry mean (16.658). P/E Ratio (35.727) is within average values for comparable stocks, (59.923). ARGX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.234). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (15.175) is also within normal values, averaging (258.761).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARGX is expected to report earnings to rise 15.89% to $2.99 per share on July 31

argenx SE ARGX Stock Earnings Reports
Q2'25
Est.
$2.99
Q1'25
Beat
by $0.34
Q4'24
Beat
by $10.57
Q3'24
Beat
by $1.24
Q2'24
Beat
by $1.35
The last earnings report on May 08 showed earnings per share of $2.58, beating the estimate of $2.24. With 42.87K shares outstanding, the current market capitalization sits at 36.10B.
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PIPR264.017.01
+2.73%
Piper Sandler Companies
VREX8.420.05
+0.60%
Varex Imaging Corp
RTO23.69-0.05
-0.21%
Rentokil Initial plc
SACH1.11-0.02
-1.77%
Sachem Capital Corp
AQB0.79-0.02
-1.98%
AquaBounty Technologies

ARGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ARGNF. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
+0.92%
ARGNF - ARGX
55%
Loosely correlated
N/A
ALNY - ARGX
47%
Loosely correlated
-2.33%
IONS - ARGX
46%
Loosely correlated
+0.14%
BBIO - ARGX
46%
Loosely correlated
+0.73%
ROIV - ARGX
44%
Loosely correlated
+0.27%
More